Literature DB >> 1130859

Twenty-four hour left ventricular bypass with a centrifugal blood pump.

E F Berstein, G A DeLaria, K H Johansen, R L Shuman, P Stasz, S Reich.   

Abstract

A new centrifugal blood pump system has been developed for left ventricular bypass by the addition of non-thrombogenic blood surface materials and an ultrathin-walled cannula for the retrograde cannulation of the left ventricle. Partial LV bypass at 3 to 6 L/min was undertaken in 55 calves without thoracotomy. In 20 it was continued for 24 hours, with 13 survivors who were eventually sacrificed. Eleven of the last 14 experiments were completed without mishap. Heparin was employed only during pump insertion. Hematologic changes were limited to moderate platelet depression, and tolerable hemolysis (average serum level 21 mg% in the last 13 experiments). Normal clotting parameters and the absence of significant fibrin split product formation correlated with the absence of gross thrombosis and few minor renal emboli observed at autopsy. This pump system appears to have several advantages over previously described equipment for LV bypass.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1130859      PMCID: PMC1343780          DOI: 10.1097/00000658-197504000-00008

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  19 in total

1.  Reduction of the oxygen utilization of the heart by left heart bypass.

Authors:  C DENNIS; D P HALL; J R MORENO; A SENNING
Journal:  Circ Res       Date:  1962-03       Impact factor: 17.367

2.  An experimental study of prolonged left heart bypass without thoracotomy.

Authors:  D P HALL; J R MORENO; C DENNIS; A SENNING
Journal:  Ann Surg       Date:  1962-08       Impact factor: 12.969

3.  Mechanical support of the circulation in acute heart failure.

Authors:  J E CONNOLLY; M B BACANER; D L BRUNS; J M LOWENSTEIN; E STORLI
Journal:  Surgery       Date:  1958-07       Impact factor: 3.982

4.  Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure.

Authors:  R D LANGDELL; R H WAGNER; K M BRINKHOUS
Journal:  J Lab Clin Med       Date:  1953-04

Review 5.  Intraaortic balloon counterpulsation. A review of physiological principles, clinical results, and device safety.

Authors:  K T Weber; J S Janicki
Journal:  Ann Thorac Surg       Date:  1974-06       Impact factor: 4.330

6.  Reduction in myocardial ischemia by left ventricular bypass after acute coronary artery occlusion.

Authors:  G A DeLaria; K H Johansen; I D Levine; E F Bernstein
Journal:  J Thorac Cardiovasc Surg       Date:  1974-05       Impact factor: 5.209

7.  Prolonged left ventricle-to-aorta pumping with left ventricular decompression using a paracorporeal pump: experimental study in the calf.

Authors:  W S Pierce; J A Brighton; W O'Bannon; W M Phillips; D L Landis; W J White; G A Prophet; J A Waldhausen
Journal:  Surg Forum       Date:  1973

8.  Intra-aortic balloon assist for postcardiotomy cardiogenic shock.

Authors:  R L Berger; V K Saini; T J Ryan; D M Sokol; J F Keefe
Journal:  J Thorac Cardiovasc Surg       Date:  1973-12       Impact factor: 5.209

9.  An efficient, compact blood pump for assisted circulation.

Authors:  E F Bernstein; F D Dorman; P L Blackshear; D R Scott
Journal:  Surgery       Date:  1970-07       Impact factor: 3.982

10.  Transarterial closed-chest left ventricular (TaCLV) bypass.

Authors:  H H Zwart; A Kralios; R Collan; W J Kolff
Journal:  Trans Am Soc Artif Intern Organs       Date:  1969
View more
  1 in total

1.  Experimental results and future prospects for a nonpulsatile cardiac prosthesis.

Authors:  R Yozu; L A Golding; G Jacobs; H Harasaki; Y Nose
Journal:  World J Surg       Date:  1985-02       Impact factor: 3.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.